This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n11	http://dx.doi.org/10.1016/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q38966136

rdf:type

wikibase:Item

schema:description

tudományos cikk научная статья 2015年論文 επιστημονικό άρθρο vetenskaplig artikel מאמר מדעי научни чланак artículo científico publicado en 2015 2015年论文 artikull shkencor scientific article published on 6 January 2015 scienca artikolo artykuł naukowy 2015年論文 artigo científico videnskabelig artikel scientific article published on 6 January 2015 artigo científico სამეცნიერო სტატია vitskapeleg artikkel bài báo khoa học научна статия 2015年論文 articol științific 2015 nî lūn-bûn bilimsel makale 2015年论文 scientific article published on 6 January 2015 wissenschaftlicher Artikel artikel ilmiah 2015年論文 ৬ জানুয়ারি ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2015년 논문 vitenskapelig artikkel мақолаи илмӣ наукова стаття, опублікована в січні 2015 vedecký článok บทความทางวิทยาศาสตร์ 2015年论文 مقالة علمية نشرت في 6 يناير 2015 teaduslik artikkel 2015年论文 wetenschappelijk artikel article scientific artikulong pang-agham naučni članak 2015年论文 article scientifique artículu científicu espublizáu en 2015 article científic 2015年の論文 2015年论文 научни чланак 2015年論文 artigo científico vědecký článek 2015 թվականի հունվարի 6-ին հրատարակված գիտական հոդված tieteellinen artikkeli articolo scientifico

p:P577

wds:Q38966136-ED82536A-31C2-4478-926E-123AFEB81E13

wdt:P577

2015-01-06T00:00:00Z

p:P407

wds:Q38966136-8A0CE846-2802-422A-8210-6665AF7138BE

wdt:P407

wd:Q1860

p:P2093

wds:Q38966136-2574618E-55FA-4094-B0EA-62ABF601BA12 wds:Q38966136-4F18938B-B1D9-4784-9B45-3708637BB464 wds:Q38966136-9BC719BB-ED12-42EB-BB53-7F6E35D890C9 wds:Q38966136-8E54878B-17EF-400A-AB3F-CDFC968E5807 wds:Q38966136-C80F9CAC-998F-4862-B88F-13E0195CE2E5 wds:Q38966136-CF3121A5-FFFD-4C9C-8A01-C06C338E9BFA

wdt:P2093

C Michael Gibson H Mesquita Gabriel EGYPT cooperation Ayse Emre Kurt Huber Giuseppe De Luca

rdfs:label

Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).

skos:prefLabel

Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).

schema:name

Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).

p:P50

wds:Q38966136-E46060FA-4618-48EA-AC8F-0A83186F1C74 wds:Q38966136-96AF0346-D197-4F52-8D76-4C47ACB2D7A9 wds:Q38966136-AA6B3AFD-E49E-4589-B5E3-4FA1ADDC9451 wds:Q38966136-6E36DBA3-413A-4186-8F2D-A01805C56988 wds:Q38966136-778466DC-A8DB-4B61-B6B8-42042A1F9C35 wds:Q38966136-827600D3-FFE2-4378-993B-120817B2D4E8 wds:Q38966136-87A96FB1-ECA9-42E9-AA47-8B2F005BF866 wds:Q38966136-01C0BC1E-26DA-42F7-8F99-A70F13DCF48C wds:Q38966136-1F536C4B-9B2E-405E-9D40-BB1B50A464FF wds:Q38966136-36D87837-A1D5-42AE-9F5B-4902D747EE8B

wdt:P50

wd:Q60959316 wd:Q50849355 wd:Q117206471 wd:Q114420195 wd:Q96581349 wd:Q106722006 wd:Q27243787 wd:Q117206472 wd:Q114328518 wd:Q59813650

p:P1476

wds:Q38966136-5049CE0C-BA58-45F3-8C2B-A1E4CBC417BE

wdt:P1476

Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation)

p:P304

wds:Q38966136-E70C4E97-8467-4D8D-84D2-C62109C144B2

wdt:P304

711-715

p:P31

wds:Q38966136-CFE5FAAE-46BE-45A6-A212-3DE3A56A4ABA

wdt:P31

wd:Q13442814

p:P921

wds:Q38966136-52E1DA68-74E0-491A-BC53-81E3640D85F7 wds:Q38966136-B4CD908D-DAAA-4C93-B784-3EC46A344835

wdt:P921

wd:Q380962 wd:Q79

p:P698

wds:Q38966136-85B9EFF8-2597-44AE-ACF9-2CA0E603F23F

wdtn:P698

n12:25655867

wdt:P698

25655867

p:P1433

wds:Q38966136-2E25ECC8-C4C5-446F-B27F-1389F6D0AC5E

wdt:P1433

wd:Q2208417

p:P433

wds:Q38966136-2333CB03-678A-4966-B008-FC8F0552CE2D

p:P478

wds:Q38966136-B1D734B5-9140-4E3E-AD24-D27D76C7665B

wdt:P433

6

wdt:P478

115

p:P356

wds:Q38966136-D5153781-494D-4902-9CB3-C3858DEE068A

wdtn:P356

n11:J.AMJCARD.2014.12.030

wdt:P356

10.1016/J.AMJCARD.2014.12.030